Follow-on participation in Monument Therapeutics' seed round.
Monument Tx is an independent UK-based biotechnology company formed as a spin-out from Cambridge Cognition in 2021
Monument Tx is an independent UK-based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system using a precision medicine approach that utilizes proprietary digital biomarkers.